Literature DB >> 16226799

Full-thickness diaphragmatic resection for stage IV ovarian carcinoma using the EndoGIA stapling device followed by diaphragmatic reconstruction using a Gore-tex graft: a case report and review of the literature.

Margrit M Juretzka1, Faith R Horton, Nadeem R Abu-Rustum, Yukio Sonoda, William R Jarnagin, Raja M Flores, Richard Barakat, Dennis S Chi.   

Abstract

BACKGROUND: Previous studies have reported the results of full-thickness diaphragmatic resection for ovarian cancer metastatic to the diaphragm. CASE: : We present the first case of an extensive full-thickness diaphragmatic resection performed using the EndoGIA [US Surgical Corp., Norwalk, CT] staple device followed by successful reconstruction using a Gore-tex (W.L. Gore and Associates, Inc., Newark, DE) graft.
CONCLUSION: Full-thickness diaphragmatic resection using the EndoGIA stapling device is a safe and effective method to completely remove extensive tumor during cytoreductive surgery. Use of the stapler expeditiously assists in removal of the specimen with minimal blood loss. In cases where large defects cannot be repaired primarily, a Gore-tex patch should be used.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16226799     DOI: 10.1016/j.ygyno.2005.09.006

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  2 in total

1.  Stapled Full-Thickness Diaphragm Resection: A Novel Approach to Diaphragmatic Resection in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.

Authors:  David N Hanna; Cameron Schlegel; Muhammad O Ghani; Andrew Hermina; Alexander S Mina; Katlyn McKay; Christina E Bailey; Deepa Magge; Kamran Idrees
Journal:  J Am Coll Surg       Date:  2022-03-08       Impact factor: 6.532

2.  Incidental events of diaphragmatic surgery in 82 patients with advanced ovarian, primary peritoneal and fallopian tubal cancer.

Authors:  Fumitoshi Terauchi; Aikou Okamoto; Yumiko Wada; Ei Hasegawa; Toru Sasaki; Osamu Akutagawa; Yasukazu Sagawa; Hirotaka Nishi; Keiichi Isaka
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.